16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
2 December - The Financial Conduct Authority ("FCA") updated the following webpages: - webpage o...
Read More >
The IRS has published Final Regulations finalizing its prior guidance that partners in a partnership...
Read More >
The cities of Austin, Dallas and San Antonio have passed ordinances that require employers to provid...
Read More >
As we previously reported, the Universal Paid Leave Amendment Act of 2016 will provide Washington, D...
Read More >
This consultation paper proposes a number of amendments to (i) simplify the offer timetable under th...
Read More >
Effective February 11, 2020, the 10 members with the largest percentage ownership in an out-of-state...
Read More >